Risedronate induces rapid and sustained reductions in vertebral fracture risk in postmenopausal women with established osteoporosis

被引：0
作者：
Eastell, R
Reid, D
Watts, N
Roux, C
Genant, H
Adami, S
Hangartner, T
Miller, P
Sorensen, O
Hooper, M
Ethgen, D
Valent, D
机构：
来源：
OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OC26
引用
收藏
页码：S26 / S27
页数：2
相关论文
共 50 条
[31]   Risedronate 5 mg/d rapidly reduces clinical vertebral fracture risk as early as 6 months in postmenopausal osteoporosis [J].
Watts, NB ;
Eastell, R .
BONE, 2003, 32 (05) :S208-S208
[32]   Risedronate reduces hip fracture risk in elderly women with osteoporosis [J].
Bensen, W ;
McClung, M .
JOURNAL OF RHEUMATOLOGY, 2001, 28 (06) :1415-1415
[33]   Risedronate reduces hip fracture risk in elderly women with osteoporosis [J].
McClung, M ;
Eastell, R ;
Bensen, W ;
Benhamou, CL ;
Chesnut, C ;
Adami, S ;
DiGennaro, J ;
Axelrod, D ;
Reginster, JY .
OSTEOPOROSIS INTERNATIONAL, 2000, 11 :S207-S207
[34]   Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis [J].
J. T. Harrington ;
L. -G. Ste-Marie ;
M. L. Brandi ;
R. Civitelli ;
P. Fardellone ;
A. Grauer ;
I. Barton ;
S. Boonen .
Calcified Tissue International, 2004, 74 :129-135
[35]   Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis [J].
Harrington, JT ;
Ste-Marie, LG ;
Brandi, ML ;
Civitelli, R ;
Fardellone, P ;
Grauer, A ;
Barton, I ;
Boonen, S .
CALCIFIED TISSUE INTERNATIONAL, 2004, 74 (02) :129-135
[36]   Risedronate for prevention and treatment of osteoporosis in postmenopausal women [J].
Recker, RR ;
Barger-Lux, J .
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (03) :465-477
[37]   Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors [J].
Roux, C ;
Reginster, JY ;
Fechtenbaum, J ;
Kolta, S ;
Sawicki, A ;
Tulassay, Z ;
Luisetto, G ;
Padrino, JM ;
Doyle, D ;
Prince, R ;
Fardellone, P ;
Sorensen, OH ;
Meunier, PJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (04) :536-542
[38]   Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors [J].
Roux, C. ;
Reginster, J. Y. ;
Fechtenbaum, J. ;
Kolta, S. ;
Sawicki, A. ;
Tulassay, Z. ;
Luisetto, G. ;
Padrino, J. M. ;
Doyle, D. ;
Prince, R. ;
Fardellone, P. ;
Sorensen, O. H. ;
Meunier, P. J. .
OSTEOPOROSIS INTERNATIONAL, 2006, 17 :S216-S216
[39]   Vertebral fracture efficacy with risedronate is apparent early and is sustained [J].
Watts, Nelson B. ;
Roux, Christian ;
Zhou, Xiaojie ;
Grauer, Andreas .
BONE, 2008, 42 :S89-S90
[40]   Vertebral fracture efficacy with risedronate is apparent early and is sustained [J].
Watts, N. B. ;
Roux, C. ;
Zhou, X. ;
Grauer, A. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 :S456-S457
12345